During the past decade, Rachel Upjohn Building, East Medical Campus conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rachel Upjohn Building, East Medical Campus" are "Healthy" (3 trials) and "Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Rachel Upjohn Building, East Medical Campus" in a lesser frequency.

Most popular intervention types in "Rachel Upjohn Building, East Medical Campus" are "Behavioral" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Methylphenidate" (2 trials), "Placebo" (2 trials), "Dual task paradigm pilot" (1 trials), "Easy Behavioral Task" (1 trials) and "Hard Behavioral Task" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rachel Upjohn Building, East Medical Campus" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Rachel Upjohn Building, East Medical Campus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Rachel Upjohn Building, East Medical Campus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rachel Upjohn Building, East Medical Campus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".